Mymetics Corp (MYMX): Development of a novel adjuvant for vacc...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Re: bow-tie post# 24377

Monday, 04/19/2021 6:31:36 PM

Monday, April 19, 2021 6:31:36 PM

Development of a novel adjuvant for vaccine sparing
Bottazzi, Maria Elena Lustigman, Sara Shen, Hao
New York Blood Center, New York, NY, United States

https://grantome.com/grant/NIH/R01-AI105431-05

RBD + rASP-1 + alum formulated into a single inoculum

https://www.researchgate.net/publication/341683983_The_Potency_of_an_Anti-MERS_Coronavirus_Subunit_Vaccine_Depends_on_a_Unique_Combinatorial_Adjuvant_Formulation

Dang ferrets

Keep Last Read

Replies (1) Next 10 Prev Next

Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/02/2024 06:16:20 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 01:00:38 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/13/2023 05:15:20 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 01:53:34 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 08:42:46 PM
Form SC 13E3 - Going private transaction by certain issuers • Edgar (US Regulatory) • 10/17/2023 07:08:56 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 01:00:41 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 10:02:57 AM
Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 09:01:04 PM

InvestorsHub NewsWire

Only $200 per official company press release!